Janus Henderson Group’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-48,498
| Closed | -$114K | – | 2475 |
|
|
2025
Q1 | $114K | Hold |
48,498
| – | – | ﹤0.01% | 2447 |
|
|
2024
Q4 | $264K | Hold |
48,498
| – | – | ﹤0.01% | 2309 |
|
|
2024
Q3 | $403K | Hold |
48,498
| – | – | ﹤0.01% | 2136 |
|
|
2024
Q2 | $348K | Sell |
48,498
-565
| -1% | -$4.05K | ﹤0.01% | 2140 |
|
|
2024
Q1 | $425K | Sell |
49,063
-408,709
| -89% | -$3.54M | ﹤0.01% | 2083 |
|
|
2023
Q4 | $3M | Sell |
457,772
-42,595
| -9% | -$279K | ﹤0.01% | 1044 |
|
|
2023
Q3 | $5M | Buy |
500,367
+124,055
| +33% | +$1.24M | ﹤0.01% | 816 |
|
|
2023
Q2 | $4.68M | Buy |
376,312
+90,771
| +32% | +$1.13M | ﹤0.01% | 881 |
|
|
2023
Q1 | $4M | Buy |
285,541
+111,120
| +64% | +$1.56M | ﹤0.01% | 946 |
|
|
2022
Q4 | $2.5M | Sell |
174,421
-200,253
| -53% | -$2.87M | ﹤0.01% | 1043 |
|
|
2022
Q3 | $9.57M | Buy |
374,674
+204,673
| +120% | +$5.23M | ﹤0.01% | 832 |
|
|
2022
Q2 | $4.83M | Buy |
170,001
+15,236
| +10% | +$433K | ﹤0.01% | 849 |
|
|
2022
Q1 | $5.46M | Sell |
154,765
-42,997
| -22% | -$1.52M | ﹤0.01% | 999 |
|
|
2021
Q4 | $8.29M | Sell |
197,762
-149,481
| -43% | -$6.26M | ﹤0.01% | 944 |
|
|
2021
Q3 | $17M | Buy |
347,243
+162,711
| +88% | +$7.99M | 0.01% | 825 |
|
|
2021
Q2 | $7.7M | Buy |
+184,532
| New | +$7.7M | ﹤0.01% | 978 |
|
|
2021
Q1 | – | Sell |
-820,275
| Closed | -$23M | – | 1606 |
|
|
2020
Q4 | $23M | Buy |
+820,275
| New | +$23M | 0.01% | 724 |
|